- Home
- XERS vs LAC Comparison
XERS vs LAC Comparison
Compare XERS & LAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | LAC |
|---|---|---|
| Founded | 2005 | 2023 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | XERS | LAC |
|---|---|---|
| Price | $6.67 | $4.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $10.43 | $6.17 |
| AVG Volume (30 Days) | 1.4M | ★ 12.8M |
| Earning Date | 03-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $44.77 | N/A |
| Revenue Next Year | $27.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.58 | $2.31 |
| 52 Week High | $10.08 | $10.52 |
Technical Indicators
Market Signals| Indicator | XERS | LAC |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 41.42 |
| Support Level | $6.26 | $4.38 |
| Resistance Level | $7.07 | $4.66 |
| Average True Range (ATR) | 0.32 | 0.28 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 25.94 | 22.48 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. Following a deal with the US government, the firm will own 59% of one resource, Thacker Pass, which is located in northwest Nevada, with automaker General Motors owning 36% and the US government owning 5%. Thacker Pass is under construction and expected to begin production in 2028. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.